Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence

About ten years ago, the first results of the so-called “Bangladesh regimen”, a short regimen lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (MDR-TB) treatment. Similar short regimens were studied in different settings, relying for their...

Full description

Bibliographic Details
Main Authors: Arnaud Trébucq, Tom Decroo, Armand Van Deun, Alberto Piubello, Chen-Yuan Chiang, Kobto G. Koura, Valérie Schwoebel
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Journal of Clinical Medicine
Subjects:
tuberculosis
treatment
mdr
9-month regimen
outcome analysis
fluoroquinolones
Online Access:https://www.mdpi.com/2077-0383/9/1/55

Internet

https://www.mdpi.com/2077-0383/9/1/55

Similar Items